Gilead Sciences, Inc. (GILD) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
fa.ray.46 fa.ray.46 02/22/2019 3 months $65.45 $66.50 +1.6% 1 Ended
Comments: http://www.gilead.com/
Netteligent Netteligent 11/30/2018 1 month $69.69 $61.88 -11.21% 11 Ended
Comments: Stuck in purgatory. Slow market. High Risks
blusignals blusignals 05/02/2018 1 month $67.68 $67.40 -0.41% 1 Ended
Comments: Alerts of Downward Trend ... Read the full entry
Kareim M. Abbouda Kareim M. Abbouda 03/15/2018 1 week $80.07 $76.49 -4.47% 4 Ended
Comments: Reversal Indicators | With RSI , EMAs and MACDs falling
raymondcollier123 raymondcollier123 09/07/2017 3 months $84.68 $73.29 -13.45% -13 Ended
Comments:
pawankumar pawankumar 09/05/2017 3 months $81.51 $75.34 -7.57% -7 Ended
Comments: At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with
Tom Ciccone Tom Ciccone 08/30/2017 3 months $80.29 $72.46 -9.75% -9 Ended
Comments:
Twillrose47 Twillrose47 05/23/2017 3 months $64.70 $72.11 +11.45% 11 Ended
Comments: Contrarian buy -- good earnings, and sales are strong (despite HEP-C decrease). Wait for turn around
AndyR AndyR 08/07/2016 3 months $80.41 $72.43 -9.92% -9 Ended
Comments: Pipeline
CETiv CETiv 08/06/2016 3 months $80.41 -20.13% 0 Ended
Comments: Needs purchase, maybe CELG. Many compeditors in Hep C field
Nirav Nirav 08/04/2016 3 months $80.10 $74.07 -7.53% -7 Ended
Comments:
DOSIS FINANCIERA DOSIS FINANCIERA 08/01/2016 3 months $79.47 $75.83 -4.58% 4 Ended
Comments:
Dono O Dono O 06/15/2016 3 months $83.60 $78.85 -5.68% -5 Ended
Comments:
michael bessey michael bessey 06/07/2016 1 Year $87.72 -26.79% 0 Ended
Comments:
TGL94 TGL94 06/05/2016 3 months $86.15 $76.89 -10.75% 10 Ended
Comments:
I2DA I2DA 05/16/2016 1 Year $83.61 $65.95 -21.12% -21 Ended
Comments:
BAM313 BAM313 04/22/2016 3 months $101.14 $86.66 -14.32% -14 Ended
Comments:
Iguler54 Iguler54 04/21/2016 3 months $100.11 $85.44 -14.65% -14 Ended
Comments:
wildcards wildcards 04/17/2016 1 month $98.29 $83.61 -14.94% -14 Ended
Comments: Peter Lynch value $298.25. Fin strength 9/10 Profit gwth 8/10 Earnings results before Mkt 26/4
Aizack Aizack 04/16/2016 1 week $98.29 $101.93 +3.7% 3 Ended
Comments:
Displaying 1-20 of 124
<< first < previous 1 2 3 4 5 6 7 last >>

Neither NASDAQ, Inc. nor any of its affiliates (collectively "NASDAQ") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ. Investors should undertake their own due diligence and carefully evaluate companies before investing.